Category: Trade Association

PhRMA Pans Government’s Response to J&J’s 340B Rebate Proposal in Letter to HRSA Administrator

October 16, 2024 William Newton, Associate Editor/Senior Writer Views

PhRMA sent an Oct. 11 letter to HRSA criticizing the agency's opposition to J&J's 340B rebate proposal.

Pharmaceutical Research and Manufacturers of America (PhRMA) expressed “serious concerns” with the federal government’s opposition to Johnson & Johnson’s (J&J’s) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider Groups, Key Federal Lawmaker Praise HRSA for Pressuring J&J to Drop 340B Rebate Proposal

October 1, 2024 William Newton, Associate Editor/Senior Writer Views

U.S. Rep. Abigail Spanberger (D-Va.) and multiple 340B provider groups applauded HRSA for its response on J&J's 340B rebate proposal.

Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Maryland, Minnesota

September 26, 2024 Bella Czajkowski, National Correspondent Views

Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates

September 24, 2024 Bella Czajkowski, National Correspondent & Shannon Young, Associate Editor/Senior Writer Views

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal

August 29, 2024 William Newton, Associate Editor/Senior Writer Views

Two major hospital groups urged the government to take enforcement action against J&J's 340B rebate proposal.

Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Announces Plans to Shift Certain 340B Discounts to Rebate Model, Prompting Fierce Backlash from Providers, Regulators

August 23, 2024 William Newton, Associate Editor/Senior Writer Views

Johnson & Johnson announced it will convert two 340B drugs to a rebate model for hospitals.

In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Pharmacist, Hospital Groups Release Joint Model State 340B Contract Pharmacy Access Legislation

August 22, 2024 William Newton, Associate Editor/Senior Writer Views

Trade groups for pharmacists and hospitals released a model state 340B contract pharmacy access bill.

Trade groups representing pharmacists and 340B health systems have jointly released model state legislation that would prohibit drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

After Failing To Disclose Conflict of Interest, JAMA Issues Correction to Piece Calling for Increased 340B Oversight and Transparency

August 13, 2024 Bella Czajkowski, National Correspondent Views

JAMA corrected an opinion piece on the 340B program to disclose one author's drug industry ties, shortly after 340B Report reported on the omission.

Two weeks after publishing an opinion piece that called for increased 340B program oversight and provider transparency, JAMA issued a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

PhRMA-Backed Conservative Think Tank Tells State Lawmakers Not to Pass 340B Contract Pharmacy Access Bills During Annual Meeting

July 30, 2024 William Newton, Associate Editor/Senior Writer Views

Leah Vukmir, a former Republican Wisconsin state lawmaker, told legislators at ALEC's annual meeting not to support 340B contract pharmacy access legislation.

An industry-funded conservative policy group known for delivering model bills to Republican lawmakers recently urged an audience of state legislators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Upcoming Federal Elections Will Significantly Impact 340B Legislative Agenda, Say 340B Hospital Lobbyist, Drug Industry Analyst

July 11, 2024 William Newton, Associate Editor/Senior Writer Views

Tom O’Donnell, senior vice president of government relations at 340B Health, and Michael McCaughan, co-founder of Provision Policy, gave a July 10 address at the 340B Coalition summer conference.

The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live